Cargando…
Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: a population-based study, 2004–2010
Autores principales: | Sabo, Ana, Tomić, Zdenko, Stilinović, Nebojša, Milijašević, Boris, Mikov, Momir, Vukmirović, Saša, Horvat, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506354/ http://dx.doi.org/10.1186/2050-6511-13-S1-A86 |
Ejemplares similares
-
Use of ACE inhibitors in Serbia in 2010
por: Milijašević, Boris, et al.
Publicado: (2012) -
Drug Information Unit, Medical Faculty of Novi Sad
por: Vukmirović, Saša, et al.
Publicado: (2012) -
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
por: Stilinović, Nebojša, et al.
Publicado: (2012) -
Considerable differences in the utilisation of antidiabetics between Serbia and Scandinavian countries
por: Pavlović, Nebojša, et al.
Publicado: (2012) -
Remarkably lower consumption of antidepressants in Serbia in comparison with Finland
por: Stojančević, Maja, et al.
Publicado: (2012)